Thomas Egebjerg
Impact in
- Hematology top 10%
- Hemophilia Treatment and Research
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments
-
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
-
- Protein purification and stability 6
- Viral Infectious Diseases and Gene Expression in Insects 4
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Pieter Spee (2 shared papers)Luis J. Sigal (2 shared papers)Mark T. Orr (2 shared papers)Min Fang (2 shared papers)Lewis L. Lanier (2 shared papers)Jais Rose Bjelke (5 shared papers)Nikolai Lorenzen (5 shared papers)Fabian Dingfelder (2 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Molecular Pharmaceutics (2 papers)Journal of Thrombosis and Haemostasis (1 paper)The Journal of Immunology (1 paper)Blood (1 paper)
- Partner nations
- DenmarkUnited StatesSwitzerland
In The Last Decade
Thomas Egebjerg
12 papers receiving 483 citations
Peers
Comparison fields: 5 of 78
- Hematology 128
- Immunology 128
- Virology 18
- Infectious Diseases 66
- Genetics 31
Countries citing papers authored by Thomas Egebjerg
This map shows the geographic impact of Thomas Egebjerg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Egebjerg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Egebjerg more than expected).
Fields of papers citing papers by Thomas Egebjerg
This network shows the impact of papers produced by Thomas Egebjerg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Egebjerg. The network helps show where Thomas Egebjerg may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Egebjerg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 127 | |
| 2 | 2011 | 92 | |
| 3 | 2020 | 68 | |
| 4 | 2021 | 66 | |
| 5 | 2020 | 57 | |
| 6 | 2010 | 42 | |
| 7 | 2023 | 21 | |
| 8 | 2024 | 8 | |
| 9 | 2023 | 5 | |
| 10 | 2019 | 5 | |
| 11 | 2025 | 2 | |
| 12 | 2024 | 1 | |
| 13 | 2024 | 0 |
About Thomas Egebjerg
Thomas Egebjerg is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases, Neurology and Immunology, having authored 13 papers that have together received 494 indexed citations. Recurring topics across this work include Protein purification and stability (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Microfluidic and Bio-sensing Technologies (2 papers), COVID-19 Clinical Research Studies (2 papers), Long-Term Effects of COVID-19 (2 papers), Immune Cell Function and Interaction (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Hematology (128 citations), Immunology (128 citations), Virology (18 citations), Infectious Diseases (66 citations) and Genetics (31 citations). Thomas Egebjerg has collaborated with scholars based in Denmark, United States and Switzerland. Frequent co-authors include Pieter Spee, Luis J. Sigal, Mark T. Orr, Min Fang, Lewis L. Lanier, Jais Rose Bjelke, Nikolai Lorenzen, Fabian Dingfelder, Lene Hansen and H. Petersen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular Pharmaceutics, Journal of Thrombosis and Haemostasis, The Journal of Immunology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.